THC Farmaceuticals Stock

THC Farmaceuticals EBIT

The EBIT of THC Farmaceuticals (CBDG) as of Aug 11, 2026 is -20,791.00 USD. In the previous year, EBIT was -29,952.00 USD — a change of -30.59% (higher).

EBIT

-20,791.00USD

YoY

-30.59%

Last updated:

In 2026, THC Farmaceuticals's EBIT was -20,791.00 USD, a -30.59% increase from the -29,952.00 USD EBIT recorded in the previous year.

The THC Farmaceuticals EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (k USD)
Date
EBIT (k USD)
Jan 1, 2017
-7.30 base
Jan 1, 2018
-15.24 base
Jan 1, 2019
-158.09 base
Jan 1, 2020
-32.70 base
Jan 1, 2021
-17.81 base
Jan 1, 2022
-8.49 base
Jan 1, 2023
-29.95 base
Jan 1, 2025
-20.79 base
YEAREBIT (k USD)
2025 -20.79
2023 -29.95
2022 -8.49
2021 -17.81
2020 -32.70
2019 -158.09
2018 -15.24
2017 -7.30
2016 -136.12
2014 -0.02
2013 -0.02
2012 -23.53
2011 -23.75
2010 -2.80
2009 10.00
Access this data via the Eulerpool API

THC Farmaceuticals Revenue

THC Farmaceuticals Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
12,949.00 USD
-7,300.00 USD
-7,300.00 USD
Jan 1, 2018
12,208.00 USD
-15,240.00 USD
-15,245.00 USD
Jan 1, 2019
10,193.00 USD
-158,090.00 USD
-498,566.00 USD
Jan 1, 2020
7,575.00 USD
-32,700.00 USD
-60,445.00 USD
Jan 1, 2021
2,234.00 USD
-17,810.00 USD
-8,420.00 USD
Jan 1, 2022
10,000.00 USD
-8,491.00 USD
426,905.00 USD
Jan 1, 2023
0.00 USD
-29,952.00 USD
-14,976.00 USD
Jan 1, 2025
0.00 USD
-20,791.00 USD
-10,395.00 USD

THC Farmaceuticals Margins

THC Farmaceuticals stock margins

The THC Farmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of THC Farmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for THC Farmaceuticals.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
100.00 %
-56.38 %
-56.38 %
Jan 1, 2018
100.00 %
-124.84 %
-124.88 %
Jan 1, 2019
74.16 %
-1,550.97 %
-4,891.26 %
Jan 1, 2020
100.00 %
-431.68 %
-797.95 %
Jan 1, 2021
57.39 %
-797.22 %
-376.90 %
Jan 1, 2022
61.92 %
-84.91 %
4,269.05 %
Jan 1, 2023
61.92 %
- %
- %
Jan 1, 2025
61.92 %
- %
- %

THC Farmaceuticals Stock analysis

What does THC Farmaceuticals do? THC Farmaceuticals Inc. is a Canadian company specializing in the production of medical cannabis products. It was founded in 2015 and is headquartered in Langley, British Columbia. The company is a registered publicly traded company, listed on the Canadian Securities Exchange (CSE) under the symbol THC and also traded on the OTC market in the USA. The company was founded by two friends, John Miller and Erik Shaw, who were both involved in agriculture and had a mutual interest in medical cannabis. They recognized the potential of the plant and began growing their own strains. Over time, they developed unique cultivars that were rich in cannabinoids and had a high therapeutic effect. Their approach has always been to produce medical cannabis of the highest quality and purity. In 2017, THC Farmaceuticals obtained the license to produce medical cannabis and started bringing its products to the market. The company has since grown in Canada and the USA and expanded its presence in the international market. THC Farmaceuticals' business model focuses on the production of medical cannabis. The company cultivates its own plants and extracts cannabinoids. The extraction of cannabinoids, such as THC and CBD, is an essential step in the production of medical cannabis. These components are offered by THC Farmaceuticals in different concentrations to meet the needs of customers. In addition, the company focuses on producing products for the medical and recreational sectors. The offered products include cannabis concentrates, oils, capsules, inhalation devices, and edible products such as candies and chocolates. THC Farmaceuticals stands out for its wide range of products to meet the needs of consumers and patients with different requirements. THC Farmaceuticals focuses on two main areas: 1. Medical sector: THC Farmaceuticals offers a wide range of cannabis products for patients with various conditions. The company works closely with doctors and healthcare professionals to ensure its products meet the needs of patients. There are numerous studies that demonstrate the efficacy of medical cannabis in treating various conditions, such as pain, epilepsy, cancer, and multiple sclerosis. 2. Recreational sector: THC Farmaceuticals also offers a wide range of cannabis products for the recreational sector. These products are intended for adults who consume cannabis for pleasure or relaxation. There is a growing demand for recreational cannabis products in Canada and the USA, especially after the legalization of cannabis in some states. THC Farmaceuticals offers a wide range of cannabis products suitable for the medical and recreational sectors. Some of the products offered by the company include: 1. Cannabis concentrates: These are highly concentrated forms of cannabis with a high therapeutic effect. THC Farmaceuticals offers a wide selection of concentrate forms, including oils, extracts, and isolates. 2. Edible products: THC Farmaceuticals offers a wide range of edible cannabis products, such as chocolates and candies. These products are a popular way to consume cannabis without smoking or inhaling it. 3. Inhalation devices: THC Farmaceuticals offers a wide range of inhalation devices, such as vaporizers and e-cigarettes. These devices provide an effective and gentle way to inhale cannabis. In conclusion, THC Farmaceuticals is a rising company specializing in the production of medical cannabis products. The company offers a wide range of products suitable for the medical and recreational sectors. With its extensive range and commitment to quality and purity, THC Farmaceuticals has become a major player in the cannabis market. THC Farmaceuticals is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing THC Farmaceuticals's EBIT

THC Farmaceuticals's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of THC Farmaceuticals's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

THC Farmaceuticals's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in THC Farmaceuticals’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about THC Farmaceuticals stock

EBIT of THC Farmaceuticals is -20,791.00 USD in 2026.

EBIT of THC Farmaceuticals changed from -29,952.00 USD to -20,791.00 USD, representing a -30.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT THC Farmaceuticals since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's THC Farmaceuticals historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — THC Farmaceuticals

All Key Metrics — THC Farmaceuticals